T-COVRIMUNE Trademark

Trademark Overview

On Monday, June 14, 2021, a trademark application was filed for T-COVRIMUNE with the United States Patent and Trademark Office. The USPTO has given the T-COVRIMUNE trademark a serial number of 90772191. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, October 16, 2024. This trademark is owned by ImmunityBio, Inc.. The T-COVRIMUNE trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations; biological preparations; pharmaceutical preparations; vaccines; immune boosters, namely, medicinal, biological and pharmaceutical preparations in the nature of vaccines; all of the aforementioned for use in the treatment and/or prevention of cancer and infectious diseases including coronavirus
t-covrimune

General Information

Serial Number90772191
Word MarkT-COVRIMUNE
Filing DateMonday, June 14, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements

Goods and ServicesMedicinal preparations; biological preparations; pharmaceutical preparations; vaccines; immune boosters, namely, medicinal, biological and pharmaceutical preparations in the nature of vaccines; all of the aforementioned for use in the treatment and/or prevention of cancer and infectious diseases including coronavirus

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunityBio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, June 17, 2021NEW APPLICATION ENTERED
Wednesday, September 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 27, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, January 19, 2022ASSIGNED TO EXAMINER
Thursday, January 27, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, January 27, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 27, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, February 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022ASSIGNED TO LIE
Thursday, October 20, 2022SOU EXTENSION 1 FILED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 20, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 20, 2022SOU EXTENSION 1 GRANTED
Friday, April 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023SOU EXTENSION 3 GRANTED
Saturday, October 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 5, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 5, 2023SOU EXTENSION 2 FILED
Wednesday, April 5, 2023SOU EXTENSION 2 GRANTED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 3 FILED
Wednesday, May 8, 2024SOU EXTENSION 4 GRANTED
Wednesday, May 8, 2024SOU EXTENSION 4 FILED
Thursday, May 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 16, 2024SOU EXTENSION 5 GRANTED
Wednesday, October 16, 2024SOU EXTENSION 5 FILED
Wednesday, October 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 8, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

covrimune preparations vaccines medicinal pharmaceutical biological infectious cancer coronavirus prevention including